Benchmark Upgrades Tesoro Corporation (TSO) to Buy; Improved Earnings Outlook
Get Alerts TSO Hot Sheet
Price: $99.53 --0%
Rating Summary:
17 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
17 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
Benchmark upgraded Tesoro Corporation (NYSE: TSO) from Sell to Buy with a price target of $25.00.
Benchmarck analyst says, "Tesoro shares upgraded to BUY from SELL with a $25 fair value target price based upon significantly improved, mid-cycle earnings outlook. Full year 2011, 2012, and mid-cycle earnings estimates raised to $5.86, $5.46, and $4.56 per share, respectively, based upon sustainable Lower 48 light, sweet crude ciscounts and several company specific initiatives. We anticipate a 2012 reinstatement of the Company’s $0.40 per share annual dividend which was suspended in late 2009."
For more ratings news on Tesoro Corporation click here and for the rating history of Tesoro Corporation click here.
Shares of Tesoro Corporation closed at $20.11 yesterday.
Benchmarck analyst says, "Tesoro shares upgraded to BUY from SELL with a $25 fair value target price based upon significantly improved, mid-cycle earnings outlook. Full year 2011, 2012, and mid-cycle earnings estimates raised to $5.86, $5.46, and $4.56 per share, respectively, based upon sustainable Lower 48 light, sweet crude ciscounts and several company specific initiatives. We anticipate a 2012 reinstatement of the Company’s $0.40 per share annual dividend which was suspended in late 2009."
For more ratings news on Tesoro Corporation click here and for the rating history of Tesoro Corporation click here.
Shares of Tesoro Corporation closed at $20.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- H.C. Wainwright Reiterates Buy Rating on Tvardi Therapeutics Inc (TVRD)
- Quanterix Corp. (QTRX) PT Lowered to $3 at Canaccord
Create E-mail Alert Related Categories
UpgradesRelated Entities
Dividend, Crude Oil, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share